tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Cory Kasimov, 48 are a HOLD (28.07%), 121 are a BUY (70.76%), 2 are a SELL (1.17%).
Analyst Cory Kasimov, currently employed at EVERCORE, carries an average stock price target met ratio of 66.69% that have a potential upside of 35.75% achieved within 335 days.
Cory Kasimov’s has documented 322 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on BNTX, BioNTech SE at 05-Aug-2026.
Analyst best performing recommendations are on EDIT (EDITAS MEDICINE).
The best stock recommendation documented was for CLVS (CLOVIS ONCOLOGY) at 10/31/2018. The price target of $16 was fulfilled within 7 days with a profit of $4.37 (37.58%) receiving and performance score of 53.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Oct-2025
$39
$9.61 (32.70%)
$35
Hold Since 04-Aug-2026
$25
$-4.39 (-14.94%)
$22
Buy Since 22-Jun-2025
$37
$7.61 (25.89%)
$36
Buy Since 16-Apr-2025
$36
$6.61 (22.49%)
$26
Hold Since 19-Jun-2022
$25
$-4.39 (-14.94%)
$24
Which stock is Cory Kasimov is most bullish on?
Which stock is Cory Kasimov is most reserved on?
What Year was the first public recommendation made by Cory Kasimov?
